Art

J-GLOBAL ID：200902264278302520   Reference number：05A0816260

Valsartan Decreases Type I Collagen Synthesis in Patients With Hypertrophic Cardiomyopathy

肥大型心筋症におけるバルサルタンのI型コラーゲン合成の抑制

Author (6)： KAWANO Hiroaki (Dep. of Cardiovascular Medicine, Course of Medical and Dental Sci., Graduate School of Biomedical Sci., Nagasaki Univ.) ,  TODA Genji (Dep. of Cardiovascular Medicine, Course of Medical and Dental Sci., Graduate School of Biomedical Sci., Nagasaki Univ.) ,  NAKAMIZO Reiichirou (Dep. of Cardiovascular Medicine, Course of Medical and Dental Sci., Graduate School of Biomedical Sci., Nagasaki Univ.) ,  KOIDE Yuji (Dep. of Cardiovascular Medicine, Course of Medical and Dental Sci., Graduate School of Biomedical Sci., Nagasaki Univ.) ,  SETO Shinji (Dep. of Cardiovascular Medicine, Course of Medical and Dental Sci., Graduate School of Biomedical Sci., Nagasaki Univ.) ,  YANO Katsusuke (Dep. of Cardiovascular Medicine, Course of Medical and Dental Sci., Graduate School of Biomedical Sci., Nagasaki Univ.)
Material： Circulation Journal  (Circ J)
Volume： 69  Issue： 10  Page： 1244-1248 (J-STAGE)  Publication year： 2005 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *hypertrophic cardiomyopathy ,...
Semi thesaurus term： randomized controlled trial ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=05A0816260&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M) ,  Clinical application of cardioactive drugs  (GW07030Y)

Substance index (2)： Valsartan ,  Aldosterone

Reference (44)：

• 1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
• 2. Maron BJ, Roberts WC. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 1979; 59: 689-706.
• 3. Maron JB. Hypertrophic cardiomyopathy: A systemic review. JAMA 2002; 287: 1308-1320.
• 4. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 2000; 35: 36-44.
• 5. Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: Insights from the Randomized Aldactone Evaluation Study (RALES). Circulation 2000; 102: 2700-2706.

Terms in the title (3)： 肥大型心筋症 ,  バルサルタン ,  I型コラーゲン